Clinical trial
The Effect of Exenatide Compared to Lantus Insulin on Vascular Function in Type…
NCT00353834 · Joslin Diabetes Center, Other · Completed
Key facts
| NCT number | NCT00353834 |
|---|---|
| Title | The Effect of Exenatide Compared to Lantus Insulin on Vascular Function in Type 2 Diabetes |
| Official title | The Effect of Exenatide Compared to Lantus Insulin on Vascular Function Before and After a Meal Tolerance Test in Patients With Type 2 Diabetes |
| Lead sponsor | Joslin Diabetes Center, Other |
| Collaborators | Amylin Pharmaceuticals, LLC. Industry Eli Lilly and Company |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Type 2 Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | Exenatide, Glargine Insulin |
| Enrollment | 72 |
| Start date | Aug 1, 2006 |
| Primary completion | Sep 1, 2010 |
| Completion | Sep 1, 2010 |
| First posted | Jul 19, 2006 |
| Last update posted | Jan 9, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: